Wilson Sonsini is proud to sponsor the Biocom San Diego CEO Summit, the premier conference designed exclusively for CEOs in the life science industry.

On November 7th at 2:15pm, Wilson Sonsini corporate partner Karen Deschaine will be moderating a panel on 2024 IPOs - Lessons Learned and the Next Chapter that includes Fred Aslan, MD from Artiva Biotherapeutics, Zack Hornby, MS, MBA from Boundless Bio, and Carmine Stengone from Contineum Therapeutics.

Then at 3:45pm, Wilson Sonsini corporate partner Zachary Myers will be moderating a panel on VC Perspectives that includes Suzanne Angell from Casdin Capital, Jon Edwards from Bioqube Ventures, Pascall Krotee, PhD, from RiverVest Venture Partners, Hunter Reed from Alexandria Venture Investments, and Tom Woiwode, PhD from Versant Ventures.

This exclusive event brings together industry leaders in a retreat-style format, fostering connections, facilitating new relationships, and providing invaluable insights.